EGFR and cystic kidney disease: The binding of nimotuzumab to EGFR in the renal cysts was implemented in the peripheral compartment, since EGFR is localized at the basolateral membrane in renal tubular cells and at both apical and basolateral membranes of cyst epithelial cells [1,6,27,28].